Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Ruf

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Gut|September 28, 2023
Immunosuppressive CD29<sup>+</sup> Treg accumulation in the liver in mice on checkpoint inhibitor therapyBenjamin L Green, Yuta Myojin, Chi Ma, et al.
Neuro-Oncology Advances|October 1, 2025
Characterization of MAIT cells in glioblastoma reveals a potential immunosuppressive role through a MAIT-neutrophil axisSeketoulie Keretsu, Taijun Hana, Alexander Lee, et al.
Journal of Hepatology|December 4, 2020
CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinomaLaurence P Diggs, Benjamin Ruf, Chi Ma, et al.
Journal of Hepatology|April 4, 2022
Metformin treatment rescues CD8<sup>+</sup> T-cell response to immune checkpoint inhibitor therapy in mice with NAFLDSimon Wabitsch, Justin D McCallen, Olena Kamenyeva, et al.
Journal for Immunotherapy of Cancer|February 8, 2023
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancerCecilia Monge, Changqing Xie, Yuta Myojin, et al.
Cancer Cell|September 2, 2022
Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLDChi Ma, Qiong Fu, Laurence P Diggs, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
The Gut Microbiome Controls Liver Tumors via the Vagus NerveKylynda C Bauer, Rajiv Trehan, Benjamin Ruf, et al.
Immunity|March 15, 2025
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TMEMohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.
Gut|August 3, 2021
The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinomaBernd Heinrich, E Michael Gertz, Alejandro A Schäffer, et al.
Cancer Discovery|December 16, 2020
Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote CholangiocarcinomaQianfei Zhang, Chi Ma, Yi Duan, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Gut|September 28, 2023
Immunosuppressive CD29<sup>+</sup> Treg accumulation in the liver in mice on checkpoint inhibitor therapyBenjamin L Green, Yuta Myojin, Chi Ma, et al.
Neuro-Oncology Advances|October 1, 2025
Characterization of MAIT cells in glioblastoma reveals a potential immunosuppressive role through a MAIT-neutrophil axisSeketoulie Keretsu, Taijun Hana, Alexander Lee, et al.
Journal of Hepatology|December 4, 2020
CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinomaLaurence P Diggs, Benjamin Ruf, Chi Ma, et al.
Journal of Hepatology|April 4, 2022
Metformin treatment rescues CD8<sup>+</sup> T-cell response to immune checkpoint inhibitor therapy in mice with NAFLDSimon Wabitsch, Justin D McCallen, Olena Kamenyeva, et al.
Journal for Immunotherapy of Cancer|February 8, 2023
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancerCecilia Monge, Changqing Xie, Yuta Myojin, et al.
Cancer Cell|September 2, 2022
Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLDChi Ma, Qiong Fu, Laurence P Diggs, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
The Gut Microbiome Controls Liver Tumors via the Vagus NerveKylynda C Bauer, Rajiv Trehan, Benjamin Ruf, et al.
Immunity|March 15, 2025
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TMEMohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.
Gut|August 3, 2021
The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinomaBernd Heinrich, E Michael Gertz, Alejandro A Schäffer, et al.
Cancer Discovery|December 16, 2020
Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote CholangiocarcinomaQianfei Zhang, Chi Ma, Yi Duan, et al.
Pageof 4